Any feedback?
Literature summary for 5.2.1.8 extracted from
- Detailed characterization of a cyclophilic from the human malaria parasite Plasmodium falciparum (1998), Biochem. J., 334, 437-445.
Cloned(Commentary)
| Cloned (Comment) | Organism |
|---|---|
| expression in Escherichia coli | Plasmodium falciparum |
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| cyclosporin A | and analogs | Plasmodium falciparum |  |
Molecular Weight [Da]
| Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
|---|---|---|---|
| 19000 | - |
x * 19000, SDS-PAGE | Plasmodium falciparum |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Plasmodium falciparum | - |
- |
- |
Purification (Commentary)
| Purification (Comment) | Organism |
|---|---|
- |
Plasmodium falciparum |
Substrates and Products (Substrate)
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| succinyl-Ala-Ala-Pro-Phe 4-nitroanilide | - |
Plasmodium falciparum | succinyl-Ala-Ala-(trans)-Pro-Phe 4-nitroanilide | - |
? | |
Subunits
| Subunits | Comment | Organism |
|---|---|---|
| ? | x * 19000, SDS-PAGE | Plasmodium falciparum |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
